Promentis Pharmaceuticals is categorized under Research and Development Laboratories in Milwaukee, WI and active since 2007.
Promentis Pharmaceuticals was established in 2007, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact David Baker at the company’s single location by writing to 9356 North Lake Drive, Milwaukee, Wisconsin WI 53217 or by phoning (262) 302-9039. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Promentis Pharmaceuticals |
| Contact Person: | David Baker |
| Address: | 9356 North Lake Drive, Milwaukee, Wisconsin 53217 |
| Phone Number: | (262) 302-9039 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Promentis Pharmaceuticals was started in 2007 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact David Baker for inquiries that concern Promentis Pharmaceuticals by calling the company number (262) 302-9039, as your correspondence is most welcome. Additionally, the physical location of the single location of Promentis Pharmaceuticals can be found at the coordinates 43.187401,-87.894836 as well as the street address 9356 North Lake Drive in Milwaukee, Wisconsin 53217.
For its online presence, you may visit Promentis Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.